Clinical Trial Update: PK/PD Study With G-Pump (Glucagon Infusion) in T1DM Patients [Phase 2]

View source ↗

Summary

Phase 2 PK/PD study evaluating G-Pump glucagon infusion in people with type 1 diabetes to treat hypoglycemia. Results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• G-Pump Glucagon Infusion (glucagon infusion)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2016-08-01